A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge

Xiangchuan He(Fudan University), Jianqing Xu(Weifang Medical University), Cuisong Zhu(Fudan University), Ziling Zhang(Fudan University), Duoduo Li(Fudan University), Zhengfan Jiang(Peking University), Xiangwei Wang(Lanzhou Veterinary Research Institute), Longfei Ding(Shanghai Public Health Clinical Center), Kangli Cao(Anhui Medical University), Chenguang Wang(Peking University), Xiaoyan Zhang(Fujian Medical University), Youhua Xie(Shanghai Medical College of Fudan University), Meilan Fu(Shanghai Public Health Clinical Center), Chenjian Gu(Washington University in St. Louis), Haoran Peng(Beijing Hospital), Yutang Li(Shanghai Medical College of Fudan University), Chen Zhao(Jiangsu Province Hospital), Zhongtian Qi(Hebei Agricultural University), Shu Song(Fudan University), Ping Zhao, Lanlan Dong(Xinjiang University), Xiujing Hong(Fudan University)
Emerging Microbes & Infections
January 1, 2021
Cited by 7


Related Papers